Optiscan Imaging
- Home ›
- AU ›
- Healthcare
Optiscan Imaging Limited engages in the development and application of confocal microscope imaging technologies for medical, translational, and pre-clinical markets in Australia, North America, Europe, and Asia. The last earnings update was 51 days ago. More info.
Add to Portfolio Compare Print
- Optiscan Imaging has significant price volatility in the past 3 months.
OIL Share Price and Events
7 Day Returns
1 Year Returns
OIL Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Optiscan Imaging (OIL) | 2.9% | -25.5% | -22.2% | -52.7% | - | -30% |
| AU Medical Equipment | 4.1% | 0.9% | 0.8% | -3.3% | 38.7% | 103.7% |
| AU Market | -0% | 1.5% | 6.5% | 4.9% | 18.2% | 4.8% |
1 Year Return vs Industry and Market
- OIL underperformed the Medical Equipment industry which returned -3.3% over the past year.
- OIL underperformed the Market in Australia which returned 4.9% over the past year.
Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
- It is not possible to calculate the future cash flow value for Optiscan Imaging. This is due to cash flow or dividend data being unavailable. The share price is A$0.035.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Optiscan Imaging's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Optiscan Imaging's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in AUD | A$-0.01 |
| ASX:OIL Share Price ** | ASX (2019-04-17) in AUD | A$0.04 |
| Australia Medical Equipment Industry PE Ratio | Median Figure of 8 Publicly-Listed Medical Equipment Companies | 33.38x |
| Australia Market PE Ratio | Median Figure of 545 Publicly-Listed Companies | 16.18x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Optiscan Imaging.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = ASX:OIL Share Price ÷ EPS (both in AUD) = 0.04 ÷ -0.01 |
-6.83x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Optiscan Imaging is loss making, we can't compare its value to the AU Medical Equipment industry average.
- Optiscan Imaging is loss making, we can't compare the value of its earnings to the Australia market.
Price based on expected Growth
Does
Optiscan Imaging's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | -6.83x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts |
Not available |
| Oceania Medical Equipment Industry PEG Ratio | Median Figure of 5 Publicly-Listed Medical Equipment Companies | 2.62x |
| Australia Market PEG Ratio | Median Figure of 360 Publicly-Listed Companies | 1.37x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for Optiscan Imaging, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Optiscan Imaging's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in AUD | A$0.01 |
| ASX:OIL Share Price * | ASX (2019-04-17) in AUD | A$0.04 |
| Australia Medical Equipment Industry PB Ratio | Median Figure of 30 Publicly-Listed Medical Equipment Companies | 2.72x |
| Australia Market PB Ratio | Median Figure of 1,676 Publicly-Listed Companies | 1.67x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = ASX:OIL Share Price ÷ Book Value per Share (both in AUD) = 0.04 ÷ 0.01 |
6.84x |
* Primary Listing of Optiscan Imaging.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Optiscan Imaging is overvalued based on assets compared to the AU Medical Equipment industry average.
Value checks
We assess Optiscan Imaging's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check) Optiscan Imaging has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Optiscan Imaging has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Unable to compare Optiscan Imaging's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
- Unable to compare Optiscan Imaging's earnings growth to the Australia market average as no estimate data is available.
- Unable to compare Optiscan Imaging's revenue growth to the Australia market average as no estimate data is available.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| Australia Medical Equipment Industry Earnings Growth Rate | Market Cap Weighted Average | 13.2% |
| Australia Medical Equipment Industry Revenue Growth Rate | Market Cap Weighted Average | 8.4% |
| Australia Market Earnings Growth Rate | Market Cap Weighted Average | 6.5% |
| Australia Market Revenue Growth Rate | Market Cap Weighted Average | 3.1% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
| Date (Data in AUD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 2 | -1 | -2 |
| 2018-09-30 | 2 | -2 | -2 |
| 2018-06-30 | 2 | -2 | -2 |
| 2018-03-31 | 2 | -3 | -2 |
| 2017-12-31 | 2 | -4 | -2 |
| 2017-09-30 | 2 | -4 | -2 |
| 2017-06-30 | 1 | -3 | -3 |
| 2017-03-31 | 1 | -2 | -3 |
| 2016-12-31 | 1 | -1 | -3 |
| 2016-09-30 | 0 | -1 | -2 |
| 2016-06-30 | 0 | -1 | -1 |
| 2016-03-31 | 0 | -1 | -1 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
All data from Optiscan Imaging Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in AUD Millions) | EPS * |
|---|---|
| 2018-12-31 | -0.01 |
| 2018-09-30 | -0.01 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | -0.01 |
| 2017-06-30 | -0.01 |
| 2017-03-31 | -0.01 |
| 2016-12-31 | -0.01 |
| 2016-09-30 | -0.01 |
| 2016-06-30 | -0.01 |
| 2016-03-31 | -0.01 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Unable to establish if Optiscan Imaging will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
Future performance checks
We assess Optiscan Imaging's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Optiscan Imaging has a total score of 0/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Optiscan Imaging performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Optiscan Imaging does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- Unable to compare Optiscan Imaging's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Unable to compare Optiscan Imaging's 1-year growth to the AU Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
All data from Optiscan Imaging Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in AUD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 1.82 | -2.21 | 1.78 | 1.51 |
| 2018-09-30 | 2.00 | -2.12 | 2.03 | 1.74 |
| 2018-06-30 | 2.19 | -2.04 | 2.28 | 1.97 |
| 2018-03-31 | 2.06 | -1.91 | 1.90 | 2.07 |
| 2017-12-31 | 1.93 | -1.78 | 1.83 | 2.16 |
| 2017-09-30 | 1.63 | -2.36 | 2.10 | 2.18 |
| 2017-06-30 | 1.33 | -2.94 | 2.36 | 2.21 |
| 2017-03-31 | 0.97 | -2.85 | 2.33 | 1.81 |
| 2016-12-31 | 0.61 | -2.75 | 2.29 | 1.40 |
| 2016-09-30 | 0.46 | -2.05 | 1.72 | 1.34 |
| 2016-06-30 | 0.31 | -1.34 | 1.15 | 1.27 |
| 2016-03-31 | 0.17 | -1.32 | 1.17 | 1.27 |
| 2015-12-31 | 0.03 | -1.29 | 1.19 | 1.27 |
| 2015-09-30 | 0.04 | -1.34 | 1.25 | 1.17 |
| 2015-06-30 | 0.05 | -1.40 | 1.32 | 1.07 |
| 2015-03-31 | 0.07 | -1.22 | 1.16 | 1.11 |
| 2014-12-31 | 0.08 | -1.05 | 1.01 | 1.15 |
| 2014-09-30 | 0.08 | -1.23 | 1.02 | 1.20 |
| 2014-06-30 | 0.08 | -1.42 | 1.02 | 1.26 |
| 2014-03-31 | 0.08 | -1.71 | 1.22 | 1.37 |
| 2013-12-31 | 0.08 | -2.00 | 1.41 | 1.48 |
| 2013-09-30 | 0.52 | -1.32 | 1.47 | 1.50 |
| 2013-06-30 | 0.97 | -0.64 | 1.52 | 1.52 |
| 2013-03-31 | 1.01 | -1.08 | 1.71 | 1.33 |
| 2012-12-31 | 1.05 | -1.52 | 1.89 | 1.14 |
| 2012-09-30 | 0.72 | -2.01 | 1.88 | 1.17 |
| 2012-06-30 | 0.38 | -2.50 | 1.87 | 1.19 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- It is difficult to establish if Optiscan Imaging has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- It is difficult to establish if Optiscan Imaging has efficiently used its assets last year compared to the AU Medical Equipment industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Optiscan Imaging improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
Past performance checks
We assess Optiscan Imaging's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Optiscan Imaging has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Optiscan Imaging's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Optiscan Imaging's finances.
The net worth of a company is the difference between its assets and liabilities.
- Optiscan Imaging is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Optiscan Imaging's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Optiscan Imaging has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Optiscan Imaging Company Filings, last reported 3 months ago.
| Date (Data in AUD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 2.21 | 0.00 | 1.04 |
| 2018-09-30 | 2.21 | 0.00 | 1.04 |
| 2018-06-30 | 3.20 | 0.00 | 1.56 |
| 2018-03-31 | 3.20 | 0.00 | 1.56 |
| 2017-12-31 | 4.10 | 0.00 | 2.27 |
| 2017-09-30 | 4.10 | 0.00 | 2.27 |
| 2017-06-30 | 1.67 | 0.00 | 0.70 |
| 2017-03-31 | 1.67 | 0.00 | 0.70 |
| 2016-12-31 | 2.26 | 0.03 | 2.49 |
| 2016-09-30 | 2.26 | 0.03 | 2.49 |
| 2016-06-30 | -0.75 | 1.12 | 0.95 |
| 2016-03-31 | -0.75 | 1.12 | 0.95 |
| 2015-12-31 | -0.19 | 0.85 | 0.92 |
| 2015-09-30 | -0.19 | 0.85 | 0.92 |
| 2015-06-30 | -0.18 | 0.51 | 0.27 |
| 2015-03-31 | -0.18 | 0.51 | 0.27 |
| 2014-12-31 | 0.04 | 0.39 | 0.91 |
| 2014-09-30 | 0.04 | 0.39 | 0.91 |
| 2014-06-30 | -0.18 | 0.13 | 0.07 |
| 2014-03-31 | -0.18 | 0.13 | 0.07 |
| 2013-12-31 | -0.14 | 0.14 | 0.34 |
| 2013-09-30 | -0.14 | 0.14 | 0.34 |
| 2013-06-30 | 0.95 | 0.00 | 0.43 |
| 2013-03-31 | 0.95 | 0.00 | 0.43 |
| 2012-12-31 | 1.63 | 0.10 | 0.82 |
| 2012-09-30 | 1.63 | 0.10 | 0.82 |
| 2012-06-30 | 0.31 | 0.21 | 0.58 |
- Optiscan Imaging has no debt.
- Optiscan Imaging currently has no debt however we can't compare to 5 years ago as we have no data for that period.
CASH RUNWAY ANALYSIS
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
- Optiscan Imaging has less than a year of cash runway based on current free cash flow.
- Optiscan Imaging has less than a year of cash runway if free cash flow continues to grow at historical rates of 28.8% each year.
Financial health checks
We assess Optiscan Imaging's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Optiscan Imaging has a total score of 4/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Optiscan Imaging's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
A$2,000 of
Optiscan Imaging
shares you are expected to receive
A$0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate Optiscan Imaging's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Optiscan Imaging's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
| Oceania Medical Equipment Industry Average Dividend Yield | Market Cap Weighted Average of 5 Stocks | 1.7% |
| Australia Market Average Dividend Yield | Market Cap Weighted Average of 417 Stocks | 4.3% |
| Australia Minimum Threshold Dividend Yield | 10th Percentile | 1.6% |
| Australia Bottom 25% Dividend Yield | 25th Percentile | 2.5% |
| Australia Top 25% Dividend Yield | 75th Percentile | 5.8% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as Optiscan Imaging has not reported any payouts.
- Unable to verify if Optiscan Imaging's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess Optiscan Imaging's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Optiscan Imaging afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Optiscan Imaging has a total score of 0/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
- Optiscan Imaging has no CEO, or we have no data on them.
Management Team
Darren Lurie
Executive Chairman
A$212K
Justin Mouchacca
CFO & Company Secretary
A$78K
2.1 yrs
Peter Delaney
Consultant
A$158K
50
0.4 yrs
Board of Directors Tenure
Average tenure of the Optiscan Imaging board of directors in years:
- The average tenure for the Optiscan Imaging board of directors is less than 3 years, this suggests a new board.
Board of Directors
Darren Lurie
Executive Chairman
A$212K
0.9 yrs
Philip Currie
Non-Executive Director
A$42K
1.8 yrs
Graeme Mutton
Non Executive Director
A$10K
1 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (A$) | Value (A$) | |
|---|---|---|---|---|---|---|---|---|---|---|
Management checks
We assess Optiscan Imaging's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Optiscan Imaging has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
Does Optiscan Imaging Limited (ASX:OIL) Have A Volatile Share Price?
Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). … While we should keep in mind that Warren Buffett has cautioned that 'Volatility is far from synonymous with risk', beta is still a useful factor to consider. … A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.
Simply Wall St - – Full articleWhat Investors Should Know About Optiscan Imaging Limited's (ASX:OIL) Financial Strength
The direct benefit for Optiscan Imaging Limited (ASX:OIL), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … Is OIL right in choosing financial flexibility over lower cost of capital … Debt capital generally has lower cost of capital compared to equity funding.
Simply Wall St - – Full articleHow Much Of Optiscan Imaging Limited (ASX:OIL) Do Insiders Own?
The big shareholder groups in Optiscan Imaging Limited (ASX:OIL) have power over the company. … Generally speaking, as a company grows, institutions will increase their ownership. … See our latest analysis for Optiscan Imaging
Simply Wall St - – Full articleOptiscan Imaging Limited (ASX:OIL): Time For A Financial Health Check
The direct benefit for Optiscan Imaging Limited (ASX:OIL), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … Does OIL's growth rate justify its decision for financial flexibility over lower cost of capital. … Debt capital generally has lower cost of capital compared to equity funding
Simply Wall St - – Full articleHow Does Optiscan Imaging Limited (ASX:OIL) Affect Your Portfolio Returns?
Generally, an investor should consider two types of risk that impact the market value of OIL. … The first risk to consider is company-specific, which can be diversified away when you invest in other companies in the same industry as OIL, because it is rare that an entire industry collapses at once. … The other type of risk, which cannot be diversified away, is market risk.
Simply Wall St - – Full articleHow Did Optiscan Imaging Limited's (ASX:OIL) Earnings Growth Stack Up Against The Industry?
Measuring Optiscan Imaging Limited's (ASX:OIL) track record of past performance is a useful exercise for investors. … View our latest analysis for Optiscan Imaging Could OIL beat the long-term trend and outperform its industry? … This suggests that though Optiscan Imaging is currently running a loss, whatever recent headwind the industry is facing, the impact on Optiscan Imaging has been softer relative to its peers.What does this mean?
Simply Wall St - – Full articleHow Optiscan Imaging Limited (ASX:OIL) Can Impact Your Portfolio Volatility
A widely-used metric to measure a stock's market risk is beta, and the broad market index represents a beta value of one. … OIL's beta implies it may be a stock that investors with high-beta portfolios might find relevant if they wanted to reduce their exposure to market risk, especially during times of downturns. … How OIL's assets could affect its beta An asset-heavy company tends to have a higher beta because the risk associated with running fixed assets during a downturn is highly expensive.
Simply Wall St - – Full articleWhat Does Optiscan Imaging Limited's (ASX:OIL) Ownership Structure Look Like?
Check out our latest analysis for Optiscan Imaging ASX:OIL Ownership_summary Apr 4th 18 Institutional Ownership Institutional investors transact in large blocks which can influence the momentum of stock prices, at least in the short-term, especially when there is a low level of public shares available on the market to trade. … This level of ownership gives retail investors the power to sway key policy decisions such as board composition, executive compensation, and potential acquisitions. … Thus, potential investors should look into these business relations and check how it can impact long-term shareholder returns.Next Steps: With a low level of institutional ownership, investors in OIL need not worry about non-fundamental factors such as ownership structure causing large impact on stock prices.
Simply Wall St - – Full articleWhen Will Optiscan Imaging Limited (ASX:OIL) Run Out Of Cash?
See our latest analysis for Optiscan Imaging What is cash burn? … The measure of how fast Optiscan Imaging goes through its cash reserves over time is called the cash burn rate. … My cash burn analysis suggests that, if Optiscan Imaging continues to spend its cash reserves at this current rate, it’ll have to raise capital within the next 6 months, which may be a surprise to some shareholders.
Simply Wall St - – Full articleInterested In Optiscan Imaging Limited (ASX:OIL)? Here's How It's Performing
View our latest analysis for Optiscan Imaging Was OIL weak performance lately part of a long-term decline? … For Optiscan Imaging, its latest trailing-twelve-month earnings is -AU$2.94M, which, in comparison to the prior year's figure, has become more negative. … This shows that whatever recent headwind the industry is facing, it’s hitting Optiscan Imaging harder than its peers.What does this mean?
Simply Wall St - – Full articleCompany Info
Description
Optiscan Imaging Limited engages in the development and application of confocal microscope imaging technologies for medical, translational, and pre-clinical markets in Australia, North America, Europe, and Asia. It offers ViewnVivo, a miniaturized fluorescence endomicroscope platform that brings imaging flexibility to preclinical research. The company also provides FIVE2 ViewnVivo system that enables virtual biopsies in living, breathing, moving tissue. It has collaboration agreement with Summit Biomedical Imaging LLC. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Details
| Name: | Optiscan Imaging Limited |
| OIL | |
| Exchange: | ASX |
| Founded: | 1994 |
| A$15,143,758 | |
| 432,678,800 | |
| Website: | http://www.optiscan.com |
| Address: |
Optiscan Imaging Limited 16 Miles Street, Mulgrave, Victoria, 3170, Australia |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| ASX | OIL | Ordinary Shares | Australian Securities Exchange | AU | AUD | 11. Aug 1997 | |
| CHIA | OIL | Ordinary Shares | Chi-X Australia | AU | AUD | 11. Aug 1997 |
Number of employees
Current staff
Industry
| Health Care Equipment | |
| Healthcare |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/20 10:31 |
| End of day share price update: | 2019/04/17 00:00 |
| Last earnings filing: | 2019/02/28 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/06/30 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
